Lanean...

Effects of a glucokinase activator on hepatic intermediary metabolism: study with (13)C-isotopomer-based metabolomics

GKAs (glucokinase activators) are promising agents for the therapy of Type 2 diabetes, but little is known about their effects on hepatic intermediary metabolism. We monitored the fate of (13)C-labelled glucose in both a liver perfusion system and isolated hepatocytes. MS and NMR spectroscopy were d...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nissim, Itzhak, Horyn, Oksana, Nissim, Ilana, Daikhin, Yevgeny, Wehrli, Suzanne L., Yudkoff, Marc, Matschinsky, Franz M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3679927/
https://ncbi.nlm.nih.gov/pubmed/22448977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BJ20120163
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!